retatrutide liver safety Retatrutide—A Game Changer in Obesity Pharmacotherapy Retatrutide Subcutaneous Fat Loss Results:

Since the comparison group included other GLP-1s, Xu and colleagues noted that the underlying mechanisms may be specific to semaglutide and tirzepatide, which may include their indirect associations with abrupt changes in metabolic parameters. NAION is rare in general, Xu told Healio

It is not FDA-approved for treating inflammation or any inflammatory condition

For example, concurrent use with corticosteroids may amplify the potential for fluid retention or electrolyte imbalance, particularly sodium and water retention

In the wake of the recent Wegovy shortage, our pipeline also identifies concerning discussions around obtaining GLP-1 RAs internationally (e.g., Mexico or Canada) through nonprescription pharmacies and online black markets where other illicit substances could be obtained